Re: lower testosterone levels with luteinizing hormone-releasing hormone agonist therapy than with surgical castration: new insights attained by mass spectrometry. T. M. van der Sluis, H. N. Bui, E. J. Meuleman, A. C. Heijboer, J. F. Hartman,N. van Adrichem, E. Boevé, W. de Ronde, R. J. van Moorselaar and A. N. Vis. J Urol 2012; 187: 1601–1607

J Urol. 2013 Mar;189(3):1168-9. doi: 10.1016/j.juro.2012.09.090. Epub 2012 Sep 25.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Castration*
  • Gonadotropin-Releasing Hormone / agonists*
  • Humans
  • Male
  • Prostatic Neoplasms / therapy*
  • Tandem Mass Spectrometry*
  • Testosterone / blood*

Substances

  • Gonadotropin-Releasing Hormone
  • Testosterone